Established in 2020, the European Innovation Council supports innovative startups and researchers with promising ideas, focusing on early-stage companies with positive environmental, social, or governance impacts. It co-invests alongside private investors.

Founded in 2019 and based in Geneva, Switzerland, Olive Capital is an angel network that provides its members access to investment opportunities in innovative, early-stage companies. Focusing primarily on the web3 sector, they leverage a deep global network of entrepreneurs to offer unique investment prospects.

Reuben Brothers is a Geneva, Switzerland-based family office founded in 2002, pursuing private equity and venture capital investments while excluding real estate development from its portfolio and engaging in debt financing.

Established in 2021 and headquartered in Geneva, Switzerland, Tayssir Capital is an investment firm specializing in venture capital. It focuses on investments within the digital assets sector.

Quadia is a regulated investment manager focused on social and environmental finance. It provides equity and debt financing and investment solutions to institutional, private and corporate clients. The firm targets investments in circular products and materials, sustainable food and agriculture, energy efficiency, smart energy, sustainable consumption and production, health and nutrition, education and urban infrastructure, with a view that sustainability supports risk management and economic valuation. Headquartered in Geneva, Switzerland, Quadia operates primarily in Europe and maintains an office in Luxembourg. Founded in 2010, it concentrates on growth capital and direct impact investments, aligning capital with sustainable development objectives.

Vinci Capital is a Swiss venture capital and private equity firm focused on mid to late venture, succession financing, owner- and management buyouts, spin-offs or carve-outs, and secondary share-backs. It invests in Swiss technology and industrial companies, typically committing CHF 7–10 million per portfolio and targeting firms with annual sales of roughly CHF 20–80 million. The firm seeks opportunities in new media technologies and services, life sciences, microelectronics and nanotechnology, and software and e-Business, and it often takes board seats and can syndicate larger rounds. Founded in 2003 and headquartered in Geneva with an office in Zug, Vinci Capital operates as a subsidiary of Vinci Partners.

Ginko Ventures is a venture capital firm founded in 2015 and based in Geneva, Switzerland. It targets technology companies across Europe and Israel, focusing on technologies, devices and solutions in connected objects, mobility, robotics, big data and artificial intelligence, with the aim of backing innovations that can rapidly reach global markets and improve how people work, play and live.

French Partners is a venture capital firm and co-investment platform founded in 2016 and based in Geneva, Switzerland. It operates as a co-investment club for qualified investors to back and support companies led by French entrepreneurs internationally. The firm targets startups and growing SMEs with revenues up to several tens of millions of euros and aims to accelerate their international presence. It typically makes minority investments ranging from €1 million to €5 million, either on its own or with co-investors.

Road Ventures is a Swiss venture capital firm focused on the transportation and mobility sector, based in Geneva and founded in 2017, backing early-stage companies with seed to Series A investments that offer innovative solutions to mobility and transportation challenges.

Merck KGaA is a German multinational chemical and pharmaceutical company founded in 1668 in Darmstadt, making it one of the oldest operating science and technology firms. It operates in three main segments: Life Science, which supplies laboratory reagents, consumables and instruments; Electronics, which provides specialty materials for semiconductors and displays; and Healthcare, which develops and markets branded pharmaceuticals with notable activity in oncology, multiple sclerosis and fertility. The company conducts business across Europe, Africa, Asia, Oceania and Latin America, and it retains the rights to the Merck name outside the United States and Canada, where Merck & Co. operates independently as MSD/EMD Serono in healthcare and MilliporeSigma in life science. Merck KGaA emphasizes scientific exploration and responsible entrepreneurship across its operations and maintains a diversified portfolio spanning research, development and manufacturing for researchers, industries and consumers.

VI Partners is a Swiss venture capital firm based in Altendorf that invests in high-growth healthcare, biotechnology, technology and software companies across Switzerland and Europe. Founded in 2001, it backs university spin-offs and other promising start-ups by providing capital, coaching and networks to help them develop and scale their businesses.

INKEF Capital is a venture capital firm based in Amsterdam, the Netherlands. It focuses on technology and healthcare, backing early-stage and Series A and growth-oriented companies across Europe. The firm pursues a patient, long-term investment approach and supports portfolio companies through multiple funding rounds as they scale. Its investments cover technology-driven sectors, including digital health, life sciences, biotechnology, enterprise software, fintech, and related fields, aiming to help entrepreneurs build successful international businesses from the Netherlands outward.

Founded in 2017, DART Ventures is a Swiss venture capital firm investing in breakthrough technologies that positively impact health and climate. The company focuses on B2B, healthtech, foodtech, clean tech, and climate tech sectors across the U.S. and Europe. DART's unique approach includes a 12-month expansion program for startups, providing strategic guidance and access to experienced partners.

CDP Venture Capital is an Italian venture capital firm founded in 2015 and based in Rome. It invests in startups and growth companies across Italy, spanning sectors such as consumer products and services, information technology, fintech and insur-tech, healthcare and life sciences, software as a service, artificial intelligence and machine learning, virtual reality, big data, advanced manufacturing, energy, education and training, agriculture materials, and other technology-driven areas. By backing early and growth-stage ventures, it aims to support Italy's economic development and the innovation ecosystem.

Omega Funds is a Boston-based venture capital firm that backs life sciences, biotechnology, health care technology and related software-enabled solutions. Founded in 2004, the firm invests across the United States and Europe, targeting pharmaceuticals, biotechnology, oncology, immunology, rare diseases, precision medicine, digital health, healthtech and cybersecurity. It manages multiple funds, including Omega Fund IV, V, VI and VII, and supports companies from early to growth stages. The firm serves as an investment adviser to its funds and seeks to build a diversified portfolio at the intersection of science and technology.

Syncona is a London-based life sciences investor focused on creating, building and scaling global leaders in health technology and medicine. It functions as the venture investing arm linked to The Wellcome Trust and concentrates on supporting startups and more mature ventures across the healthcare sector, with emphasis on gene therapy, targeted cell therapy, and advanced diagnostics. The firm pursues a global investment approach, typically committing between £1 million and £20 million per company and participates as a majority investor or in syndicates. Established in 2012, Syncona aims to partner with scientists and entrepreneurs to translate innovative science into transformative treatments and durable value for patients.

Amboy Street Ventures is a venture capital firm founded in 2021 and based in Los Angeles. It targets investments in fertility, sexual health, and women’s health technology startups, supporting companies advancing health tech in the United States and Europe.

Gaingels is a venture investment organization focused on LGBTQ+-founded and led companies and their allies, investing across stages from pre-seed to pre-IPO and maintaining a global portfolio. Founded in 2014 and based in New York, it operates as a syndicate with more than 130 portfolio companies and around $70 million deployed. The organization supports inclusive leadership by backing ventures that promote diverse C-suite and board representation and actively assists portfolio companies in recruiting diverse executive talent. It also fosters a global community of industry leaders, investors, operators, and entrepreneurs who pursue positive social change through business and successful investments.

Verve Ventures is a Switzerland-based venture capital firm and digital investment platform that connects qualified private and institutional investors with startups across Europe. Founded in 2010, it operates a fully digital platform that enables investors to build diversified portfolios with investments starting at 10,000 CHF or EUR. The firm maintains a pan-European network of investors, including family offices and pension funds, and is backed by Zürcher Kantonalbank. An in-house investment team screens thousands of startups annually and selects the top 1% after rigorous due diligence. Verve Ventures sources deals, structures rounds, and facilitates investor participation while also supporting portfolio companies with hiring, client introductions, and access to an expert network. Its portfolio spans sectors such as science and technology, climate energy, robotics, industrial data analytics, advanced manufacturing, digital health, and clean energy infrastructure, and the firm operates with offices in Zurich, Lausanne, Berlin, Paris, and Cambridge as it engages across Europe.

Mayo Clinic is a non-profit medical organization based in Rochester, Minnesota, established in 1863. It provides comprehensive medical care, education in clinical medicine and biomedical sciences, and conducts extensive medical research across a broad range of specialties. The organization integrates patient care with education and research to advance medical practice and outcomes. It also advances innovation through Mayo Clinic Platform, a Rochester-based accelerator that incubates and invests in early-stage health-tech startups in collaboration with providers, pharmaceutical and device companies, health-tech developers, and patients; and Mayo Clinic Ventures, the organization's venture arm that partners with physicians and scientists to commercialize inventions and discoveries to improve patient care and support Mayo’s education and research missions.

LIFTT is a venture capital firm established in 2019 and located in Turin, Italy. The firm focuses on investing in technology companies, aiming to support innovative ventures that demonstrate potential for growth and impact. By targeting the technology sector, LIFTT seeks to foster the development of new ideas and solutions, contributing to the advancement of the industry while generating returns for its investors.

Panakes Partners is a Milan-based venture capital firm founded in 2015 that makes early-stage investments in life sciences and healthcare companies across Europe and Israel. It supports ambitious teams developing innovative technologies and products in areas such as diagnostic equipment and healthcare technology systems, with the goal of improving patient outcomes and advancing medical solutions.

Occident is a venture capital firm that invests in deep tech start-ups, with a focus on spin-offs from scientific research that aim to deliver real-world impact. It operates as an owner-managed investor with offices in Munich and Zug. The firm supports start-ups in the life sciences and industrial tech sectors from the seed stage onward and accompanies portfolio companies over the long term, providing both financial backing and the team's extensive experience. It invests its own money and makes decisions based on sustainable potential for success. The approach emphasizes collaboration with founding teams and a commitment to addressing societal challenges in a sustainable way.

Spicehaus Partners is an independent Swiss venture capital firm based in Zug that backs early-stage technology companies in Switzerland, with an emphasis on B2B technology firms; founded in 2018 and owned by its partners, the firm combines investment experience with entrepreneurial expertise and actively supports its portfolio companies to promote growth, aiming to foster long-term partnerships between entrepreneurs and investors.

NEXT VENTŪRES is a venture capital firm founded in 2018 and located in Austin, Texas. The firm specializes in investments within the sports, fitness, nutrition, and wellness sectors. With a team that possesses extensive expertise and strong industry connections, NEXT VENTŪRES is equipped to generate substantial value for both its investors and portfolio companies.

ACE & Company is a Geneva-based private equity and venture capital firm with offices in London, Cairo, Hong Kong, and New York. It makes global private market investments across multiple stages and strategies, including angel, early, growth, mature, buyout, special situations, and secondaries, and engages in co-investments and leading or participating roles. The firm operates on a sector-agnostic basis, targeting opportunities across technology, financial services, healthcare, energy, consumer goods, and services, and seeks to deliver long-term value by tailoring investment exposure to each company's development stage and risk profile.

LGT Capital Partners is a global alternative investment manager based in Pfaeffikon, Switzerland. Established in 1994, the firm specializes in private markets and liquid alternatives, offering private equity, real estate, debt and hedge fund solutions, along with multi-asset and long-only programs for institutional clients. It serves pension funds, sovereign wealth funds, insurers and banks, and operates offices worldwide. The firm uses a bottom-up approach to manager selection and pursues opportunities across buyouts, growth and venture in private markets, including primary investments, co-investments and secondaries, as well as hedge funds and private equity fund of funds.

TeleSoft Partners is a venture capital investment firm founded in 1996 and based in Aspen, Colorado. It provides value-added capital and strategic support to technology, energy, and related sectors across the United States, helping entrepreneurs grow early-, mid-, and late-stage companies. The firm emphasizes leveraging its knowledge, contacts, and experience to accelerate growth and exits, and has participated in the development of more than 75 companies, with over 50 acquisitions or public offerings.

Paradigm is a crypto-focused investment firm based in San Francisco that funds early-stage companies and protocols in the cryptocurrency space. Founded in 2018 by Matt Huang and Fred Ehrsam, the firm emphasizes research as the core of its approach, aiming to advance crypto technology, economics, and the emergence of a new internet platform for money and governance. It acts as both investor and builder, developing open-source software and tools to push the frontier of crypto. The team collaborates on research papers and provides guidance on product and business strategy for ambitious projects at the frontier.

Section 32 is a California-based venture capital firm founded in 2017 by Bill Maris. It concentrates on early-stage investments in life sciences, healthcare, and technology across the United States. The firm seeks to back frontier technologies that accelerate discovery, development, and dissemination of transformative solutions that improve the human condition. Its investment scope spans artificial intelligence, enterprise software, cybersecurity, fintech, quantum computing, computational biology, and biotechnology, with multi-million-dollar checks and a diversified portfolio of companies.

Athos Capital is a venture capital firm founded in 2016 and based in Madrid, Spain, that provides early-stage capital to technology companies across Europe, with a particular emphasis on Spain. It targets startups in areas including cloud-based farm management software, data storage, the Internet of Things, corporate accommodation platforms, and financial and educational technology.

Nauta Capital is a pan-European venture capital firm backing early-stage B2B software companies. Headquartered in London with offices in Barcelona and Munich, it operates across Europe and targets Series A to late seed and Series B investments in technology ventures. The firm focuses on B2B software with strong network effects, vertically oriented enterprise tech for large industries, and deep-tech applications that address enterprise challenges, including sectors such as retail tech, revenue tech, fintech, insurtech, health tech, enterprise software, developer tools, infrastructure, AI and ML, and security and privacy. With more than half a billion in assets under management and a team of around 20 professionals, Nauta is regarded as one of Europe’s larger B2B-focused investors.

Maverick Capital is a global investment firm established in 1993 that manages capital through long/short hedged equity strategies and private investments, with offices in New York, San Francisco, London, Hong Kong, Philadelphia and Dallas. The firm seeks to grow and preserve capital for qualified investors, conducting deep fundamental research and actively partnering with portfolio companies to support growth, including deploying resources and taking board seats. Maverick Capital also operates Maverick Ventures, its venture arm based in San Francisco, which funds startups from seed through growth across healthcare, software and deep technology, leveraging the parent firm’s resources and experience to help entrepreneurs build scalable businesses.

Ecosystem Ventures is a venture capital investment and strategic consulting firm that backs seed- and early-stage technology companies and assists them through growth toward Series A. The firm emphasizes sustainable technologies and innovative business ideas, offering consulting services in the American, Indian, and European markets. Founded in 2005 and based in California, it pursues long-term partnerships with entrepreneurs to build durable businesses.

Insight Partners is a global software investor that partners with growth-stage technology and software companies. Headquartered in New York City with offices in London, Tel Aviv, and Palo Alto, it concentrates on growth-stage software, internet, and data services, with notable focus areas including fintech, cybersecurity, AI/ML, DevOps, and healthcare. Founded in 1995, Insight Partners manages over $75 billion in regulatory assets under management and has invested in more than 750 companies worldwide, with over 55 portfolio companies achieving an IPO. The firm combines capital with hands-on, right-sized software expertise to support portfolio companies on their growth journey from first investment to IPO.

Gimv is a European investment company specializing in private equity and venture capital, founded in 1980 and headquartered in Antwerp, Belgium. It focuses on investments in business-to-business services, financial services, healthcare, information technology, technology, media and entertainment, telecommunications, manufacturing and life sciences, with activity across Belgium, France, Germany, the Netherlands and Switzerland. The firm manages a substantial portfolio, overseeing about 1.8 billion euros of investments across 85 portfolio companies, which together generate more than 6 billion euros in turnover and employ over 28,000 people.

123 Investment Managers is an independent investment firm based in Paris with offices in Lyon, specializing in private asset investments across venture capital, private equity, and fund of funds. It pursues direct investments in a broad range of stages from seed to mature growth and co-investment opportunities, primarily in technology, industry, renewable energy, and consumer sectors, and also in health-related and eldercare services, hotels, clinics, and other accommodation ventures. The firm focuses on Europe, with emphasis on France, Switzerland, the United States, and Canada, and targets portfolio company enterprise values roughly €5 million to €400 million, investing typically from about €0.8 million to €8 million per deal. It also offers multi-theme private asset strategies across tourism, healthcare, infrastructure, and real estate to help private and institutional clients access unlisted French companies and long-term value creation.

TPY Capital is an Israeli investment firm based in Tel Aviv that operates as a private equity and venture capital firm, focusing on early-stage, pre-revenue, revenue-stage, and growth technology companies. It is an active investor that typically leads rounds and concentrates on sectors such as quantum computing, cloud infrastructure, data and analytics, fintech, enterprise software, machine learning, enterprise digitalization, and human augmentation. The firm backs Israeli startups, generally pursuing minority positions and supporting companies through multiple growth stages. Founded in 2011, TPY Capital aims to support innovative technology firms across Israel.

ProQuest Investments is a healthcare venture capital firm founded in 1998 that provides seed to late-stage financing to healthcare and biotechnology companies. The firm manages over $875 million in capital and operates offices in Princeton, San Diego, and Montreal. It has a focus on therapeutics and has investments across oncology, pain, and infectious disease, seeking long-term partnerships with entrepreneurs.

Global Finance is an independent investment firm founded in 1991 in Athens, Greece, and has been a pioneer of private equity and venture capital in Southeast Europe. Its operations include private equity fund management, real estate development, and advisory services, with equity investments in mid-market companies across sectors such as manufacturing, information technology, specialty retail, media and entertainment, healthcare, telecommunications, and services. The firm concentrates on opportunities in Greece and neighboring Southeast European markets and maintains a regional footprint with offices and activity in Sofia, Belgrade, Bucharest, and London. Typical investments are up to €40 million in Greece and up to €15 million for Eastern European ventures. Exit options include trade sales, initial public offerings, management buybacks, and sales to other investors. Global Finance aims to create value for investors and dynamic companies by supporting growth and improving operational performance in Southeast Europe.